1 Min Read
Nov 14 (Reuters) - Aralez Pharmaceuticals Inc :
* Aralez pharmaceuticals -new post-hoc analysis supports yosprala efficacy and safety in previous heart attack patients who need daily aspirin therapy Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.